一名接受甲氧苄啶-磺胺甲恶唑治疗的患者出现甲氨蝶呤毒性。
Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole.
作者信息
Thomas M H, Gutterman L A
出版信息
J Rheumatol. 1986 Apr;13(2):440-1.
PMID:3487652
Abstract
A 61-year-old patient with rheumatoid arthritis receiving treatment with methotrexate developed bone marrow hypoplasia after treatment with trimethoprim-sulfamethoxazole. The bone marrow recovered after stopping methotrexate.
摘要
一名61岁的类风湿关节炎患者在接受甲氨蝶呤治疗，并用甲氧苄啶-磺胺甲恶唑治疗后出现骨髓发育不全。停用甲氨蝶呤后骨髓恢复。
Zotero 插件